Hypertension Trial, Recruiting NCT05676970 Sponsor: Xavier University of Louisiana. Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05676970
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 55 years old
  • People who are able to speak English
  • People who are currently working in, or training for, industries such as healthcare, education, beauty, hospitality, food/culinary, or industrial plant work
  • People who are able to use telehealth technology through a tablet, mobile phone, or computer

Who may not be able to join:

  • People who are not able to give informed consent to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sara Al-Dahir, PhD, Xavier University of Louisiana.

Phone: 5045205766

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xavier University of Louisiana.
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Willingness to participate in preventative medicine screening for Diabetes, Hypertension and Hyperlipidemia; Participating in Screening for DM, hypertension, hyperlipidemia; Willingness to participate in personalized exercise and nutrition goals to prevent chronic disease; Participating in personalized exercise and nutrition goals; Participating in personalized medication compliance for prescription, over the counter, herbals and nutraceuticals related to health promotion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov